1. Home
  2. MRVI vs AMPX Comparison

MRVI vs AMPX Comparison

Compare MRVI & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • AMPX
  • Stock Information
  • Founded
  • MRVI 2014
  • AMPX 2008
  • Country
  • MRVI United States
  • AMPX United States
  • Employees
  • MRVI N/A
  • AMPX N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • AMPX Industrial Machinery/Components
  • Sector
  • MRVI Health Care
  • AMPX Miscellaneous
  • Exchange
  • MRVI Nasdaq
  • AMPX Nasdaq
  • Market Cap
  • MRVI 312.4M
  • AMPX 261.6M
  • IPO Year
  • MRVI 2020
  • AMPX N/A
  • Fundamental
  • Price
  • MRVI $2.22
  • AMPX $2.66
  • Analyst Decision
  • MRVI Hold
  • AMPX Strong Buy
  • Analyst Count
  • MRVI 10
  • AMPX 7
  • Target Price
  • MRVI $6.84
  • AMPX $8.71
  • AVG Volume (30 Days)
  • MRVI 1.9M
  • AMPX 3.3M
  • Earning Date
  • MRVI 05-12-2025
  • AMPX 05-08-2025
  • Dividend Yield
  • MRVI N/A
  • AMPX N/A
  • EPS Growth
  • MRVI N/A
  • AMPX N/A
  • EPS
  • MRVI N/A
  • AMPX N/A
  • Revenue
  • MRVI $241,856,000.00
  • AMPX $33,115,000.00
  • Revenue This Year
  • MRVI N/A
  • AMPX $160.31
  • Revenue Next Year
  • MRVI $10.73
  • AMPX $224.32
  • P/E Ratio
  • MRVI N/A
  • AMPX N/A
  • Revenue Growth
  • MRVI N/A
  • AMPX 209.20
  • 52 Week Low
  • MRVI $1.67
  • AMPX $0.61
  • 52 Week High
  • MRVI $10.03
  • AMPX $4.21
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 52.01
  • AMPX 51.59
  • Support Level
  • MRVI $2.20
  • AMPX $2.34
  • Resistance Level
  • MRVI $2.41
  • AMPX $3.17
  • Average True Range (ATR)
  • MRVI 0.15
  • AMPX 0.19
  • MACD
  • MRVI 0.01
  • AMPX -0.00
  • Stochastic Oscillator
  • MRVI 58.06
  • AMPX 37.95

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

Share on Social Networks: